Professor Stephen Jackson has been awarded the Biochemical Society's GlaxoSmithKline Award ‘for distinguished research leading to new advances in medical science'.
Professor Stephen Jackson has been awarded the Biochemical Society's GlaxoSmithKline Award ‘for distinguished research leading to new advances in medical science'.
Professor Stephen Jackson has been awarded the Biochemical Society's GlaxoSmithKline Award ‘for distinguished research leading to new advances in medical science'.
This award recognises his standing as one of the international leaders in the field of DNA and chromosome damage and repair. Defects in these processes can be the causes of many diseases, most notably cancer.
His work has lead to clinical trials of drugs being developed that may be effective at killing cells that contain mutant breast cancer susceptibility genes BRCA1 and BRCA2.
Winners of the Biochemical Society's GlaxoSmithKline award receive a beautiful glass sculpture designed by Katharine Dowson.
Professor Stephen Jackson is the Frederick James Quick Professor of Biology and the Head of Cancer Research UK Laboratories at The Wellcome Trust and Cancer Research UK Gurdon Institute.
This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.